Cargando…
Retargeting azithromycin analogues to have dual-modality antimalarial activity
BACKGROUND: Resistance to front-line antimalarials (artemisinin combination therapies) is spreading, and development of new drug treatment strategies to rapidly kill Plasmodium spp. malaria parasites is urgently needed. Azithromycin is a clinically used macrolide antibiotic proposed as a partner dru...
Autores principales: | Burns, Amy L., Sleebs, Brad E., Siddiqui, Ghizal, De Paoli, Amanda E., Anderson, Dovile, Liffner, Benjamin, Harvey, Richard, Beeson, James G., Creek, Darren J., Goodman, Christopher D., McFadden, Geoffrey I., Wilson, Danny W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526119/ https://www.ncbi.nlm.nih.gov/pubmed/32993629 http://dx.doi.org/10.1186/s12915-020-00859-4 |
Ejemplares similares
-
Targeting malaria parasites with novel derivatives of azithromycin
por: Burns, Amy L., et al.
Publicado: (2022) -
System-wide biochemical analysis reveals ozonide antimalarials initially act by disrupting Plasmodium falciparum haemoglobin digestion
por: Giannangelo, Carlo, et al.
Publicado: (2020) -
Peroxide Antimalarial Drugs Target Redox Homeostasis
in Plasmodium falciparum Infected Red
Blood Cells
por: Siddiqui, Ghizal, et al.
Publicado: (2022) -
Current and emerging target identification methods for novel antimalarials
por: Challis, Matthew P., et al.
Publicado: (2022) -
Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum
por: Wilson, Danny W, et al.
Publicado: (2015)